The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 23, 2025

Filed:

Aug. 31, 2021
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

President and Fellows of Harvard College, Cambridge, MA (US);

The General Hospital Corporation, Boston, MA (US);

Trustees of Boston University, Boston, MA (US);

Inventors:

Pardis Sabeti, Cambridge, MA (US);

Shira Weingarten-Gabbay, Cambridge, MA (US);

Susan Klaeger, Cambridge, MA (US);

Jenn Abelin, Cambridge, MA (US);

Mohsan Saeed, Boston, MA (US);

Nir Hacohen, Boston, MA (US);

Siranush Sarkizova, Cambridge, MA (US);

Steven Carr, Cambridge, MA (US);

Karl Clauser, Cambridge, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/215 (2006.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01); A61P 31/14 (2006.01); G01N 33/569 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61K 45/06 (2013.01); A61P 31/14 (2018.01); G01N 33/56983 (2013.01); G01N 33/6818 (2013.01); A61K 2039/53 (2013.01); G01N 2333/165 (2013.01); G01N 2800/26 (2013.01);
Abstract

Immunogenic compositions comprising one or more polypeptides, wherein the one or more polypeptides: is capable of binding to Major Histocompatibility Complex (MHC) class I, and is derived from one or more proteins of SARS-COV-2. Also provided include methods of treating and preventing diseases using the immunogenic compositions.


Find Patent Forward Citations

Loading…